StockData

Kymera Therapeutics vs Vir Biotechnology

KYMR and VIR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How KYMR and VIR compare

Kymera Therapeutics is the larger company, worth 6.6 times as much as Vir Biotechnology ($10.4B against $1.6B).

Vir Biotechnology grew revenue faster over the last twelve months (1496% versus 134% for Kymera Therapeutics).

Vir Biotechnology keeps more of each dollar of sales as profit, with a net margin of −83.0% compared with −342% at Kymera Therapeutics.

Vir Biotechnology scores higher on the StockData Score (11 against 9 for Kymera Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricKYMRVIR
Size and price
Market cap$10.4B$1.6B
Share price$121.52$9.25
Change, 1 year87.1%64.3%
Change, 5 years126%−74.3%
Beta (5Y)0.590.80
Employees238367
StockData Score
Total score911 (better)
Valuation score03 (better)
Growth score11
Performance score22
Health score6 (better)5
Dividend score00
Valuation
P/S101×5.2× (better)
P/B6.4×1.6× (better)
FCF yield−2.8% (better)−13.0%
Fair value$37.15$13.31
Margin of safety−227%30.5% (better)
Growth
Revenue growth (TTM)134%1496% (better)
Revenue growth, 5Y average2.9% (better)−2.1%
Profitability
Gross margin0.00%–
Operating margin−396%−92.4% (better)
Net margin−342%−83.0% (better)
FCF margin−283%−67.1% (better)
Return on equity−27.3%−26.1% (better)
Return on invested capital−59.0%−55.2% (better)
Financial health
Debt / equity0.000.00
Current ratio11.13 (better)6.04
Altman Z-score39.62 (better)2.57
Piotroski F-score4 (better)3
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions114%86.6%
Held by insiders38.3%17.1%
Insider net buying, 12 months−$301M−$4.0M (better)
Short interest, % of float16.0%12.0%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.